speb/financial-data huggingface dataset:
DQ7A.IR cash_flow (annual, 2025-08-31) — Repurchase Of Capital Stock: -5041000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Retained Earnings: 10644000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Retained Earnings: 10644000.00
DQ7A.IR cash_flow (annual, 2025-08-31) — Sale Of Investment Properties: 112000.00
DQ7A.IR cash_flow (annual, 2025-08-31) — Sale Of PPE: 77000.00
DQ7A.IR income_statement (annual, 2025-08-31) — Selling And Marketing Expense: 0.00
DQ7A.IR income_statement (annual, 2025-08-31) — Selling General And Administration: 1154000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Share Issued: 1228431.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Share Issued: 1228431.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Stockholders Equity: 12847000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 12847000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Tangible Book Value: 12847000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: 12847000.00
DQ7A.IR income_statement (annual, 2025-08-31) — Tax Effect Of Unusual Items: -92000.00
DQ7A.IR income_statement (annual, 2025-08-31) — Tax Provision: 1000.00
DQ7A.IR income_statement (annual, 2025-08-31) — Tax Rate For Calcs: 0.13
DQ7A.IR balance_sheet (annual, 2025-08-31) — Taxes Receivable: 25000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Taxes Receivable: 25000.00
DQ7A.IR cash_flow (annual, 2025-08-31) — Taxes Refund Paid: -498000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Assets: 18446000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Assets: 18446000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Capitalization: 12847000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Capitalization: 12847000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Debt: 0.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Debt: 0.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Equity Gross Minority Interest: 12317000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 12317000.00
DQ7A.IR income_statement (annual, 2025-08-31) — Total Expenses: 1154000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Liabilities Net Minority Interest: 6129000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 6129000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Non Current Assets: 0.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Non Current Assets: 0.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 0.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 0.00
DQ7A.IR income_statement (annual, 2025-08-31) — Total Operating Income As Reported: -1887000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Total Tax Payable: 0.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Total Tax Payable: 0.00
DQ7A.IR income_statement (annual, 2025-08-31) — Total Unusual Items: -736000.00
DQ7A.IR income_statement (annual, 2025-08-31) — Total Unusual Items Excluding Goodwill: -736000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Treasury Stock: 309000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Treasury Stock: 309000.00
DQ7A.IR balance_sheet (annual, 2025-08-31) — Working Capital: 12317000.00
DQ7A.IR balance_sheet (quarterly, 2025-08-31) — Working Capital: 12317000.00
DR.TO cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -10342000.00
DR.TO balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 15843000.00
DR.TO balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 15843000.00
DR.TO income_statement (annual, 2021-12-31) — Earnings From Equity Interest: -125000.00
DR.TO cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 125000.00
DR.TO income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
DR.TO balance_sheet (annual, 2021-12-31) — Investments And Advances: 1117000.00
DR.TO balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 1117000.00
DR.TO balance_sheet (annual, 2021-12-31) — Net Debt: 18526000.00
DR.TO income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
DR.TO cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -18107000.00
DR.TO balance_sheet (annual, 2021-12-31) — Non Current Note Receivables: 13384000.00
DR.TO balance_sheet (annual, 2021-12-31) — Other Current Assets: 9749000.00
DR.TO balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 1117000.00
DR.TO income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -11539000.00
DR.TO income_statement (annual, 2021-12-31) — Other Operating Expenses: -13099000.00
DR.TO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 9749000.00
DR.TO cash_flow (annual, 2021-12-31) — Purchase Of Business: -267000.00
DR.TO cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -18107000.00
DR.TO income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
DR.TO income_statement (annual, 2021-12-31) — Write Off: 0.00
DR.TO income_statement (annual, 2022-12-31) — +Operating Expense: 229138000.00
DR.TO income_statement (annual, 2022-12-31) — +Total Revenue: 424551000.00
DR.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 26402000.00
DR.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 64040000.00
DR.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -101955000.00
DR.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1192000.00
DR.TO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -7268000.00
DR.TO income_statement (annual, 2022-12-31) — Amortization: 638000.00
DR.TO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 638000.00
DR.TO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 638000.00
DR.TO income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 638000.00
DR.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 28539000.00
DR.TO income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
DR.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 29366985.00
DR.TO income_statement (annual, 2022-12-31) — Basic EPS: -0.15
DR.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 61044000.00
DR.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 92866000.00
DR.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -6718000.00
DR.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 57361000.00
DR.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 353237000.00
DR.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 34926000.00
DR.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 34926000.00
DR.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -7495000.00
DR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -77353000.00
DR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -5775000.00
DR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 57013000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 2462000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -2610000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Inventory: 1422000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -3508000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Payable: -1046000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -3656000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1381000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -2596000.00
DR.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -6211000.00
DR.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2596000.00
DR.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -26115000.00
DR.TO balance_sheet (annual, 2022-12-31) — Common Stock: 353237000.00
DR.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -7495000.00
DR.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 79134000.00
DR.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -38384000.00
DR.TO balance_sheet (annual, 2022-12-31) — Construction In Progress: 838000.00
DR.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 143925000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 22211000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Assets: 119329000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 10183000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Debt: 9729000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 19912000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 12335000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 12335000.00
DR.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 86819000.00
DR.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 5208000.00
DR.TO cash_flow (annual, 2022-12-31) — Deferred Tax: 5208000.00
DR.TO cash_flow (annual, 2022-12-31) — Depreciation: 20125000.00
DR.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 20763000.00
DR.TO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 20763000.00
DR.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 20763000.00
DR.TO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 20763000.00
DR.TO income_statement (annual, 2022-12-31) — Depreciation Income Statement: 20125000.00
DR.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 29366985.00
DR.TO income_statement (annual, 2022-12-31) — Diluted EPS: -0.15
DR.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -4405000.00
DR.TO balance_sheet (annual, 2022-12-31) — Dividends Payable: 1539000.00
DR.TO income_statement (annual, 2022-12-31) — EBIT: 30389000.00
DR.TO income_statement (annual, 2022-12-31) — EBITDA: 51152000.00
DR.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -574000.00
DR.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 574000.00
DR.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -3000.00
DR.TO cash_flow (annual, 2022-12-31) — End Cash Position: 34926000.00
DR.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -77353000.00
DR.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 50295000.00
DR.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -282000.00
DR.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
DR.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -3000.00
DR.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 198213000.00
DR.TO balance_sheet (annual, 2022-12-31) — Goodwill: 120623000.00
DR.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 133723000.00
DR.TO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 71308000.00
DR.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 226674000.00
DR.TO income_statement (annual, 2022-12-31) — Gross Profit: 280626000.00
DR.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 16549000.00
DR.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 0.00
DR.TO income_statement (annual, 2022-12-31) — Interest Expense: 12886000.00
DR.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 12886000.00
DR.TO income_statement (annual, 2022-12-31) — Interest Income: 8543000.00
DR.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 8543000.00
DR.TO cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -10408000.00
DR.TO balance_sheet (annual, 2022-12-31) — Inventory: 9227000.00
DR.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 164727000.00
DR.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5775000.00
DR.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
DR.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 12749000.00
DR.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 6237000.00
DR.TO balance_sheet (annual, 2022-12-31) — Leases: 42343000.00
DR.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 47178000.00
DR.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 75864000.00
DR.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 123042000.00
DR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 12749000.00
DR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -19222000.00
DR.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
DR.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 77077000.00
DR.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 35558000.00
DR.TO income_statement (annual, 2022-12-31) — Minority Interests: -16700000.00
DR.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 943000.00
DR.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -38384000.00
DR.TO balance_sheet (annual, 2022-12-31) — Net Debt: 50667000.00
DR.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 3000.00
DR.TO income_statement (annual, 2022-12-31) — Net Income: -4405000.00
DR.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -4405000.00
DR.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 12295000.00
DR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -4405000.00
DR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -4405000.00
DR.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 12295000.00
DR.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 12295000.00
DR.TO income_statement (annual, 2022-12-31) — Net Interest Income: -4869000.00
DR.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -6473000.00
DR.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -6473000.00
DR.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -4869000.00
DR.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -25001000.00
DR.TO balance_sheet (annual, 2022-12-31) — Net PPE: 124719000.00
DR.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -6718000.00
DR.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -54589000.00
DR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 20000.00
DR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 15884000.00
DR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 20000.00
DR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 15884000.00
DR.TO balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 0.00
DR.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 79694000.00
DR.TO income_statement (annual, 2022-12-31) — Normalized Income: 15644356.68
DR.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 57013000.00
DR.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 295000.00
DR.TO income_statement (annual, 2022-12-31) — Operating Income: 51488000.00
DR.TO income_statement (annual, 2022-12-31) — Operating Revenue: 424551000.00
DR.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 25915962.00
DR.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 10549000.00
DR.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 9729000.00
DR.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 4420000.00
DR.TO income_statement (annual, 2022-12-31) — Other Gand A: 70861000.00
DR.TO income_statement (annual, 2022-12-31) — Other Income Expense: -29116000.00
DR.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 13100000.00
DR.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4860000.00
DR.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 37354000.00
DR.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -11990000.00
DR.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 10162000.00
DR.TO balance_sheet (annual, 2022-12-31) — Other Payable: 12335000.00
DR.TO balance_sheet (annual, 2022-12-31) — Other Properties: 7313000.00
DR.TO balance_sheet (annual, 2022-12-31) — Payables: 40276000.00
DR.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 62487000.00
DR.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 10549000.00
DR.TO income_statement (annual, 2022-12-31) — Pretax Income: 17503000.00
DR.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
DR.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -730000.00
DR.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -6718000.00
DR.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 9227000.00
DR.TO balance_sheet (annual, 2022-12-31) — Receivables: 64627000.00
DR.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 143925000.00
DR.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 20763000.00
DR.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -19222000.00
DR.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -38384000.00
DR.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -275295000.00
DR.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 127352000.00
DR.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 1673000.00
DR.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 198213000.00
DR.TO balance_sheet (annual, 2022-12-31) — Share Issued: 25915962.00
DR.TO income_statement (annual, 2022-12-31) — Special Income Charges: -28539000.00
DR.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: -667000.00
DR.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 79134000.00
DR.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -54589000.00
DR.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -8492643.32
DR.TO income_statement (annual, 2022-12-31) — Tax Provision: 5208000.00
DR.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.30
DR.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 587000.00
DR.TO cash_flow (annual, 2022-12-31) — Taxes Refund Paid: 2339000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Assets: 377791000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 154998000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Debt: 142954000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 114692000.00
DR.TO income_statement (annual, 2022-12-31) — Total Expenses: 373063000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 263099000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 258462000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 176280000.00
DR.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 34939000.00
DR.TO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 526000.00
DR.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
DR.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -28542000.00
DR.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -28542000.00
DR.TO balance_sheet (annual, 2022-12-31) — Working Capital: 32510000.00
DR.TO income_statement (annual, 2022-12-31) — Write Off: 11990000.00
DR.TO income_statement (annual, 2023-12-31) — +Operating Expense: 170035000.00
DR.TO income_statement (annual, 2023-12-31) — +Total Revenue: 339576000.00
DR.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 23152000.00
DR.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 61766000.00
DR.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -99809000.00
DR.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 716000.00
DR.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -5573000.00
DR.TO income_statement (annual, 2023-12-31) — Amortization: 1308000.00
DR.TO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1308000.00
DR.TO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 1308000.00
DR.TO income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 1308000.00
DR.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 786000.00
DR.TO income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
DR.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 25254834.00
DR.TO income_statement (annual, 2023-12-31) — Basic EPS: 0.73
DR.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 34926000.00
DR.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 93150000.00
DR.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -16053000.00
DR.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 47710000.00
DR.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 348099000.00
DR.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 24113000.00
DR.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 24113000.00
DR.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -6071000.00
DR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -69826000.00
DR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -13667000.00
DR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 72714000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -2483000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -934000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -205000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Payable: -2483000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3417000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2105000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 1029000.00
DR.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -488000.00
DR.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 1029000.00
DR.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -10779000.00
DR.TO balance_sheet (annual, 2023-12-31) — Common Stock: 348099000.00
DR.TO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -6071000.00
DR.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 85988000.00
DR.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -7422000.00
DR.TO balance_sheet (annual, 2023-12-31) — Construction In Progress: 590000.00
DR.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 120365000.00
DR.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 20694000.00
DR.TO balance_sheet (annual, 2023-12-31) — Current Assets: 102757000.00
DR.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 9159000.00
DR.TO balance_sheet (annual, 2023-12-31) — Current Debt: 14350000.00
DR.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 23509000.00
DR.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 82961000.00
DR.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 8325000.00
DR.TO cash_flow (annual, 2023-12-31) — Deferred Tax: 8325000.00
DR.TO cash_flow (annual, 2023-12-31) — Depreciation: 20229000.00
DR.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 21537000.00
DR.TO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 18305000.00
DR.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 21537000.00
DR.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 18305000.00
DR.TO income_statement (annual, 2023-12-31) — Depreciation Income Statement: 16997000.00
DR.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 25254834.00
DR.TO income_statement (annual, 2023-12-31) — Diluted EPS: 0.73
DR.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 18503000.00
DR.TO balance_sheet (annual, 2023-12-31) — Dividends Payable: 1503000.00
DR.TO income_statement (annual, 2023-12-31) — EBIT: 50894000.00
DR.TO income_statement (annual, 2023-12-31) — EBITDA: 72431000.00
DR.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -320000.00
DR.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 320000.00
DR.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -34000.00
DR.TO cash_flow (annual, 2023-12-31) — End Cash Position: 24113000.00
DR.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -69826000.00
DR.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 56661000.00
DR.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -2487000.00
DR.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 2487000.00
DR.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -34000.00
DR.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 151730000.00
DR.TO balance_sheet (annual, 2023-12-31) — Goodwill: 120623000.00
DR.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 131875000.00
DR.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 67339000.00
DR.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 219992000.00
DR.TO income_statement (annual, 2023-12-31) — Gross Profit: 219211000.00
DR.TO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
DR.TO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 10000.00
DR.TO income_statement (annual, 2023-12-31) — Interest Expense: 15984000.00
DR.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 15984000.00
DR.TO income_statement (annual, 2023-12-31) — Interest Income: 717000.00
DR.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 717000.00
DR.TO cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -10825000.00
DR.TO balance_sheet (annual, 2023-12-31) — Inventory: 9008000.00
DR.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 155087000.00
DR.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -13667000.00
DR.TO balance_sheet (annual, 2023-12-31) — Land And Improvements: 13266000.00
DR.TO balance_sheet (annual, 2023-12-31) — Leases: 31128000.00
DR.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 38551000.00
DR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 54749000.00
DR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 93300000.00
DR.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -28842000.00
DR.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 73648000.00
DR.TO balance_sheet (annual, 2023-12-31) — Minority Interest: 32315000.00
DR.TO income_statement (annual, 2023-12-31) — Minority Interests: -25496000.00
DR.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 2386000.00
DR.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -7422000.00
DR.TO balance_sheet (annual, 2023-12-31) — Net Debt: 44986000.00
DR.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 34000.00
DR.TO income_statement (annual, 2023-12-31) — Net Income: 18503000.00
DR.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 18503000.00
DR.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 28846000.00
DR.TO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 15153000.00
DR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 18503000.00
DR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 3350000.00
DR.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 43999000.00
DR.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 43999000.00
DR.TO income_statement (annual, 2023-12-31) — Net Interest Income: -15613000.00
DR.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -28842000.00
DR.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -28842000.00
DR.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -15613000.00
DR.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -27491000.00
DR.TO balance_sheet (annual, 2023-12-31) — Net PPE: 120183000.00
DR.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -16053000.00
DR.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -45887000.00
DR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 70000.00
DR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 20234000.00
DR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 70000.00
DR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 20234000.00
DR.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 70764000.00
DR.TO income_statement (annual, 2023-12-31) — Normalized Income: 1972564.25
DR.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 72714000.00
DR.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -2133000.00
DR.TO income_statement (annual, 2023-12-31) — Operating Income: 49176000.00
DR.TO income_statement (annual, 2023-12-31) — Operating Revenue: 339576000.00
DR.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 24724462.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 7137000.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 14350000.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 2136000.00
DR.TO income_statement (annual, 2023-12-31) — Other Gand A: 62782000.00
DR.TO income_statement (annual, 2023-12-31) — Other Income Expense: 1347000.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 11252000.00
DR.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 16150000.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 40087000.00
DR.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -786000.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Payable: 11957000.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Properties: 8210000.00
DR.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 7137000.00
DR.TO balance_sheet (annual, 2023-12-31) — Payables: 36622000.00
DR.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 57316000.00
DR.TO income_statement (annual, 2023-12-31) — Pretax Income: 34910000.00
DR.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
DR.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: -8000.00
DR.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -16053000.00
DR.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 9008000.00
DR.TO balance_sheet (annual, 2023-12-31) — Receivables: 69636000.00
DR.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 117133000.00
DR.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 21537000.00
DR.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -28842000.00
DR.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -7422000.00
DR.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -262827000.00
DR.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 88948000.00
DR.TO cash_flow (annual, 2023-12-31) — Sale Of Business: 2394000.00
DR.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 151730000.00
DR.TO balance_sheet (annual, 2023-12-31) — Share Issued: 24724462.00
DR.TO income_statement (annual, 2023-12-31) — Special Income Charges: 1701000.00
DR.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: -476000.00
DR.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 85988000.00
DR.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -45887000.00
DR.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 289564.25
DR.TO income_statement (annual, 2023-12-31) — Tax Provision: 6064000.00
DR.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.17
DR.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 733000.00
DR.TO cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -4161000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Assets: 354885000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 140737000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Debt: 116809000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 118303000.00
DR.TO income_statement (annual, 2023-12-31) — Total Expenses: 290400000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 236582000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 252128000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 153621000.00
DR.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 49176000.00
DR.TO income_statement (annual, 2023-12-31) — Total Other Finance Cost: 346000.00
DR.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 10000.00
DR.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 1667000.00
DR.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1667000.00
DR.TO balance_sheet (annual, 2023-12-31) — Working Capital: 19796000.00
DR.TO income_statement (annual, 2023-12-31) — Write Off: 786000.00
DR.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 23769680.00
DR.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.30
DR.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 23769680.00
DR.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.30
DR.TO income_statement (quarterly, 2024-09-30) — Earnings From Equity Interest: 0.00
DR.TO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 0.00
DR.TO cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
DR.TO balance_sheet (quarterly, 2024-09-30) — Net Debt: 36080000.00
DR.TO income_statement (quarterly, 2024-09-30) — Other Operating Expenses: -11957000.00
DR.TO cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
DR.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
DR.TO income_statement (quarterly, 2024-09-30) — Write Off: 0.00
DR.TO income_statement (annual, 2024-12-31) — +Operating Expense: 120773000.00
DR.TO income_statement (annual, 2024-12-31) — +Total Revenue: 246088000.00
DR.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 16940000.00
DR.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 45468000.00
DR.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -53256000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -53256000.00
DR.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 470000.00
DR.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -5424000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -5424000.00
DR.TO income_statement (annual, 2024-12-31) — Amortization: 540000.00
DR.TO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 540000.00
DR.TO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 540000.00
DR.TO income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 540000.00
DR.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 2265000.00
DR.TO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 2265000.00
DR.TO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
DR.TO income_statement (annual, 2024-12-31) — Average Dilution Earnings: 0.00
DR.TO income_statement (quarterly, 2024-12-31) — Average Dilution Earnings: 0.00
DR.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 24000877.00
DR.TO income_statement (annual, 2024-12-31) — Basic EPS: 3.06
DR.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 24113000.00
DR.TO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 48327000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 48327000.00
DR.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -7068000.00
DR.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 39714000.00
DR.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 316927000.00
DR.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 108496000.00
DR.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 108496000.00
DR.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -6103000.00
DR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -84261000.00
DR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 85419000.00
DR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 83284000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: -495000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 5154000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -476000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Payable: -12452000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -7298000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 902000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Receivables: 5228000.00
DR.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -1644000.00
DR.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 5228000.00
DR.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 84442000.00
DR.TO balance_sheet (annual, 2024-12-31) — Common Stock: 316927000.00
DR.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -6103000.00
DR.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 122019000.00
DR.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -16614000.00
DR.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 196000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 196000.00
DR.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 72945000.00
DR.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 20809000.00
DR.TO balance_sheet (annual, 2024-12-31) — Current Assets: 165335000.00
DR.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 8909000.00
DR.TO balance_sheet (annual, 2024-12-31) — Current Debt: 10390000.00
DR.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 19299000.00
DR.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 88949000.00
DR.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -3672000.00
DR.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -3672000.00
DR.TO cash_flow (annual, 2024-12-31) — Depreciation: 18829000.00
DR.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 19369000.00
DR.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 11468000.00
DR.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 19369000.00
DR.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 11468000.00
DR.TO income_statement (annual, 2024-12-31) — Depreciation Income Statement: 10928000.00
DR.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 24000877.00
DR.TO income_statement (annual, 2024-12-31) — Diluted EPS: 3.06
DR.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 73490000.00
DR.TO balance_sheet (annual, 2024-12-31) — Dividends Payable: 1441000.00
DR.TO income_statement (annual, 2024-12-31) — EBIT: 53928000.00
DR.TO income_statement (annual, 2024-12-31) — EBITDA: 73297000.00
DR.TO income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 0.00
DR.TO income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 0.00
DR.TO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
DR.TO cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
DR.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -59000.00
DR.TO cash_flow (annual, 2024-12-31) — End Cash Position: 108496000.00
DR.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -84261000.00
DR.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 76216000.00
DR.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: -33643000.00
DR.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: -33643000.00
DR.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
DR.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 0.00
DR.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -59000.00
DR.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 116590000.00
DR.TO balance_sheet (annual, 2024-12-31) — Goodwill: 90600000.00
DR.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 97826000.00
DR.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 50892000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 50892000.00
DR.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 136260000.00
DR.TO income_statement (annual, 2024-12-31) — Gross Profit: 173143000.00
DR.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 2265000.00
DR.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 13766000.00
DR.TO income_statement (annual, 2024-12-31) — Interest Expense: 11677000.00
DR.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 11677000.00
DR.TO income_statement (annual, 2024-12-31) — Interest Income: 1861000.00
DR.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1861000.00
DR.TO cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -9481000.00
DR.TO balance_sheet (annual, 2024-12-31) — Inventory: 5805000.00
DR.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 156242000.00
DR.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 85419000.00
DR.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 9374000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 9374000.00
DR.TO balance_sheet (annual, 2024-12-31) — Leases: 26922000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Leases: 26922000.00
DR.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 30805000.00
DR.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 23833000.00
DR.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 54638000.00
DR.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -32818000.00
DR.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 46599000.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 46599000.00
DR.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 25433000.00
DR.TO income_statement (annual, 2024-12-31) — Minority Interests: -32072000.00
DR.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 92487000.00
DR.TO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 92487000.00
DR.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -16614000.00
DR.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 59000.00
DR.TO income_statement (annual, 2024-12-31) — Net Income: 73490000.00
DR.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 73490000.00
DR.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 48265000.00
DR.TO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 57297000.00
DR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 73490000.00
DR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 16193000.00
DR.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 105562000.00
DR.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 105562000.00
DR.TO income_statement (annual, 2024-12-31) — Net Interest Income: -10060000.00
DR.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -32818000.00
DR.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -32818000.00
DR.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -10060000.00
DR.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -28726000.00
DR.TO balance_sheet (annual, 2024-12-31) — Net PPE: 83004000.00
DR.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -7068000.00
DR.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 24193000.00
DR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 129000.00
DR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 15952000.00
DR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 129000.00
DR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 15952000.00
DR.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 73356000.00
DR.TO income_statement (annual, 2024-12-31) — Normalized Income: 16243150.00
DR.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 83284000.00
DR.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -33584000.00
DR.TO income_statement (annual, 2024-12-31) — Operating Income: 52370000.00
DR.TO income_statement (annual, 2024-12-31) — Operating Revenue: 246088000.00
DR.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 23023762.00
DR.TO cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
DR.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 10390000.00
DR.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 16694000.00
DR.TO income_statement (annual, 2024-12-31) — Other Gand A: 50843000.00
DR.TO income_statement (annual, 2024-12-31) — Other Income Expense: -59000.00
DR.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 7226000.00
DR.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 11038000.00
DR.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 39303000.00
DR.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: -7285000.00
DR.TO income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 0.00
DR.TO balance_sheet (annual, 2024-12-31) — Other Properties: 4842000.00
DR.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 5479000.00
DR.TO balance_sheet (annual, 2024-12-31) — Payables: 32147000.00
DR.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 52956000.00
DR.TO income_statement (annual, 2024-12-31) — Pretax Income: 42251000.00
DR.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
DR.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
DR.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
DR.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
DR.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -7068000.00
DR.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 5805000.00
DR.TO balance_sheet (annual, 2024-12-31) — Receivables: 51034000.00
DR.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 65044000.00
DR.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 19369000.00
DR.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -32818000.00
DR.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -16614000.00
DR.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -195378000.00